Skip to main content
SVYSF $26.73
SVYSF · Solvay S A
Track SVYSF — free
$26.73 At close · Oct 30 Play latest call Q2 2026 earnings call transcript
Market Cap
$2.80B
Shares
104.72M
Volume · Oct 30 200 Avg daily vol (3M) 416
All webcasts

Earnings call · FY2026 Q1

Solvay S A (SVYSF) Q1 2026 Earnings Call Transcript

Concluded May 7, 2026 Audio replay Verified speakers
May 7, 2026 54:08 55 turns
Period
FY2026 Q1
Runtime
54:08
Sources
3 artifacts
Open full screen Slides 21

Transcript & audio

Verified speakers 54:08 Audio
Geoffroy Loutremont Head of Investor Relations

Good afternoon, everyone, and welcome to Solvay's first quarter 2026 earnings call. I'm Geoffrey Loutremont, Head of Investor Relations, and I'm joined today by our CEO, Philippe Keren, and our CFO, Alexandre Blum. This call is being recorded and will be accessible for replay on the Investor Relations section of Solvay's website later today. We'd like to remind you that the presentation includes forward-looking statements that are subject to risk and uncertainties. And the slides presented in today's call are also available on our website. Let's get started. Philippe, over to you.

Thank you Geoffroy and hello everyone. As you know, safety is at the core of our operations and we continue to work hard on the different programs we have in place in the organization and they are already delivering tangible results. A word also on our Solvay employees located in the Middle East. They are all safe and this is our top priority. We monitor the situation on a daily basis and we are ready to act swiftly to support them if necessary. Turning now to the results on slide slide 6. Our first quarter shows the resilience of Solvay in a macro environment that continues to be challenging. Overall, the situation in the Middle East had a limited impact on our results this quarter, although there are several effects that we are actively mitigating. The most direct impact concerns our Saudi Arabian HPPO peroxides business, with production and temporarily suspended since mid-March. We follow the situation very closely, and we will be ready to start up again as soon as the situation clarifies. Then the conflict has a direct impact on our energy, raw materials, and transportation costs. We are mitigating this with price increases, including the activation of pass-through clauses in our energy-intensive businesses. And I will come back to this later in the call. Finally, indirect effects may materialize from disruptions in the value chain and further pressure on demand in some end markets. This could be partially offset by improved market conditions for the co-authors business, which, by the way, also benefits from lower tariffs between Brazil and the U.S. Besides this, we haven't seen any major change in our main market dynamics. The demand environment remained overall soft, and we continue to see some price pressure for our sodage seaborn activities in Southeast Asia. The Coatis business remains down year on year, but it is showing clear signs of improvement on a sequential basis. Alex, over to you for the details of the Q1 results.

Thank you, Philippe, and good morning, good afternoon, everyone. Our financial performance in Q1 highlighted again that most of our activities are resilient, and our free cash flow in the first quarter showed that the very strong performance of Q4 2025 was not realized at the expense of 2026. All of this allows us to continue executing our strategy and transformation while maintaining a healthy balance sheet. Let's now move to the detail, and as usual, I will comment on organic evolution, meaning at constant scope and currency, unless otherwise stated. Moving to slide eight. Underlying net sales in Q1 reached close to 1 billion euro. 9% lower compared to the first quarter of 2021. Overall volumes proved resilient, with only limited decline in certain product lines against a stronger comparative base. Pricing pressure was mainly concentrated, again, in the sodash seaborn market and in Qatis, both of which started to soften in Q2 last year. Forex remained a headwind as the start of the quarter, or weaker dollar against the euro. Now moving to EBITDA. Looking at the year-on-year comparison, there are two important elements to consider. On the one side, a positive impact from the CO2 emission right sales, and on the other side, the negative impact from the strategic cost. We delivered an EBITDA of 219 million euro during the first quarter, down 10%. The ABD margin remained steady at a solid 21.9%. Volume and mix was positive, supported by the sales of CO2 emission line, which generated 38 million euros in January. Excluding this, volumes would have decreased by 17 million euros versus a strong comparison base in Q1 2025. five net pricing decline was limited to minus 30 million euro with lower prices in some of our businesses being partly offset by reduction in viable cost these were driven by cost setting initiatives and effective energy management on fixed cost our ongoing cost initiatives at both plant and corporate levels are allowing us to absorb inflation the negative impact shown in bridge mainly reflects the temporary stranded cost linked to the exit from the tsa with science code the expected negative year-on-year impact of the full 2026 is mostly concentrated in the first quarter moving on to segment review i'll start with basic chemicals on slide 10. sodash and derivative sales were down 7% year-on-year. Sodash volumes for the quarter were overall flat, up slightly in the seaborne market and marginally down in North America. In terms of production, we continue to shift some of the seaborne volume from European plants to our green river site in North America. Combined with lower energy costs, this allowed us to reduce variable costs and partially offset the impact of lower soda-hash prices. Our bicarbonate business, on the other hand, continue to be very resilient, with volumes only marginally lower in flu gas treatment application, given a slower start of the year. Peroxide sales for the quarter decreased by 6% compared to Q1 2025. The electronic-grade business once again delivered double-digit growth in volumes driven by demand from the semiconductor industry on the other hand both volume and pricing were slightly down in the merchant market as well in our as well as in our HPPO and intermediate businesses compared to a high 2025 pace the segment EBDA was down 17 percent reflecting primarily the impact of lower sodash pricing especially in the seaborn market but also a slight negative mix across two business units. Moving on to performance chemical on slide 11. Silica sales declined by 7%, reflecting a lower tire volume compared to a stronger Q1 of last year, which had benefited from some customer restocking. In the Coatis business, sales were down 16% compared to 1, 2025, which was the last quarter before the announcement of the U.S. tariff on Brazil. Although still at a low level, business performance has improved sequentially each month so far this year. The improvement has been supported first by the reduction in U.S. tariffs and by reduced pressure from China following Middle East-related supply disruption. Finally, in our While special care business sales declined by 11%, this is mainly due to lower volume on electronic errors, which also benefited from pre-buying and restocking in the first quarter of last year. Although they remain marginal, we have started seeing the first contribution from volumes for permanent magnet applications. The overall segment EBDA was down 8% with lower net pricing inquiries as the primary Before we move to the free cash flow, a quick word on corporate segment EBITDA, as it delivered a positive contribution of 6 million for Q1 2026. As explained earlier, this is due to the 38 million gain from further optimization of our portfolio of European CO2 emission rights, which more than offset the higher temporary stranded cost. Turning now to the free cash flow on slide 12. I am pleased to highlight our resilient cash generation. Even with a particularly strong cash performance in 2025 in general and in Q4 in particular, we continue to deliver positive free cash flow quarter after quarter. Our capex spending remains very disciplined in Q1, with investment targeted mostly towards essential capex, covering HSNE, maintenance, and ongoing energy transition projects. Working capital saw negative variation, broadly in line with the usual Q1 seasonality, despite record low working capital position at year end. As we had announced, provisioned cash out is progressively reducing, but is still above our normalized level due to the transformation restructuring project. This is mainly linked to the TSA exit, to the fluorine, the business footprint optimization, and to some remaining cash out from the Dombal energy transition project. Moving on to the net debt bridge on slide 13. Underlying net debt increased by a limited 0.1 billion euro in Q1, mainly from the interim dividend payment in January. Our leverage ratio remained very healthy at 2. As you know, maintaining a healthy balance sheet and preserving our investment grade rating is a cornerstone of Solveig's financial policy. In conclusion, our financial results prove that despite the pressure from the external factors, Solvay has the ability to continue generating solid free cash flow quarter after quarter. Philippe, back to you for an update on Solvay energy management in 2026.

Thank you Alex. So I will now share how we manage our energy exposure at Solvay. We have a relatively sizable energy footprint and Europe is a large part of it. But we have a strong and highly experienced energy team with a clear mandate focusing on optimizing energy costs and delivering on our energy transition objectives. So even in the context of rising energy prices, we do not expect to see a material impact on our bottom line. As we walk you through the figures, there are two key takeaways. First, our energy transition roadmap is successfully driving the decline of our exposure to fossil fuels year after year. And second, we have contractual arrangements in most of our energy intensive businesses, allowing us to limit the impact of energy cost fluctuations. And this disciplined approach also applies to our raw materials. Solvay's energy consumption, as disclosed in our annual report, amounts to around 18 terawatts per annum. This represents a total spend of just over 500 million euros per year. Over the past two years, our total energy costs have been reduced by approximately 30 percent, benefiting from the lower energy prices in Europe. At the same time, we've been structurally reducing our overall exposure to fossil fuels which are by definition more volatile as recent events have once again shown we already shared our coal phase out initiatives notably in green river where coal has been replaced by locally sourced natural gas and in reinberg germany where it has been replaced by recycled biomass together these projects have allowed for a one-third reduction in our coal consumption. Let me also illustrate this transition from fossil fuels with a very recent example. Two months ago, our new electric furnace in Cologne, France, started to produce silicate using electricity, which in France is both competitive and low carbon. This replaces the fuel-based furnace and allows us to almost entirely eliminate the group's remaining oil exposure, which was already below 1% of the group consumption before. Overall, these efforts are clearly reflected in the evolution of our energy consumption. Over the past two years, our fossil fuel consumption has declined by 10% in volume, while biomass consumption has increased by 60 percent and even up by 150 percent if we compare to four years ago. Now, moving to slide 16, 18 of our 43 production sites are located in Europe, including some of our highly energy intensive activities, such as synthetic sodage. As a result, Europe accounts for two-thirds of the total energy spent of Solvay today. This is the only region where we still use coal, which was historically the main source of energy for our sod ash plants. In 2025, coal and coal products still represent half of the energy spent, while natural gas exposure in Europe is more limited. Both will decline in the coming years as we move away from fossil fuel towards renewable alternatives. So, as I've shared with you, we act and we take our energy transition as an opportunity to be more competitive and more independent from the short-term fluctuations on the global energy markets. Moving on to slide 17, where we illustrate our proactive approach to manage risks related to energy and also to raw materials costs. So being an energy intensive company, Solveig has built core competencies in the energy domain together with a robust risk mitigating model. First, we act strategically to structurally reduce our exposure to the most volatile feedstocks. On the energy side, this is driven by our energy transition out of fossil fuels, which I've just illustrated. On raw materials, our exposure to oil and gas-derived feedstocks is largely concentrated in one single business, Coatis. Additionally, we benefit from a high degree of vertical integration across many of our activities, which significantly reduces our external exposure to raw materials fluctuations. Second, the remaining exposure is primarily managed through commercial pass-through mechanisms. Since 2022, energy clauses and protection mechanisms cover the majority of the group sales. Finally, for the residual energy exposure that cannot be passed through contractually, we make limited and targeted use of financial hedging. So taken together, all these mechanisms significantly reduce Solvay's exposure to energy and raw material price volatility, and in that way, effectively limiting the impact on our bottom line. Now, moving to the outlook. While the conflict in the Middle East is adding another layer of challenges and volatility, our guidance for the year 2026 remains unchanged. Underlying EBITDA between 770 and 850 million euros. Free cash flow to solve their shareholders from continuing operations to exceed 200 million euros with capex under 300 million euros. So in conclusion, our essential chemistry strategy is more relevant than ever in the current environment. And we can see our efforts to transform the company are paying off. For example, our energy transition projects, especially in Europe, allow us to disconnect from the volatility in the market by using alternative energy sources. Our local-to-local model proves very relevant as well. We remain close to customers and we use local raw materials whenever possible. we remain fully committed to our strategy and we are confident it will allow us to continue to navigate external uncertainty and to build a stronger more resilient and solve it for the future next to that we continue to protect our financial strengths with a very clear focus on cash generation thank you for listening and now we're happy to take your questions with Thank you, Philippe and Alexandre.

Geoffroy Loutremont Head of Investor Relations

Gaia, can you please open the line now for the questions?

Operator

Ladies and gentlemen, if you wish to ask a question, please dial pound key five on your telephone keypad. If you wish to withdraw your question, please dial pound key six. The first question is coming from Martin Rudiger from Kepler Chevron. Your line is now open.

Martin Rudiger Analyst — Kepler Cheuvreux

Please go ahead yes thanks for taking my two questions firstly on the demand situation many other chemical companies mentioned that their business in March was clearly better than January and February I hope that it's the same also for you please confirm that and looking at the business in the last five weeks ie April and the beginning of May and also factoring in what you see in your order book for the upcoming weeks to come. Do you have the impression that the demand right now stays on the same level as in March? That's my first question. Second question is on the seabore market for soda ash. Most of the Chinese producers use either the Hu process or the Sol Day process to produce soda ash, which is a very in energy intense process now energy availability energy costs become a topic in China do you see that a competition is easing in the CBO market since the start of the Middle East conflict and B but you see that pricing is sequentially improving in that region thank you Thank you very much, Martin, for your questions, and I will first maybe ask Alex to make an update on the situation of March and April regarding the demand on the different businesses,

and then I will probably take the question on Solache. Alex?

Yeah. Hello, Martin. Yes, indeed. We have seen, yeah, January, February were quite soft and we've seen some improvement that's true in basic chemical i've mentioned merchant market the bicarbonate and since march and april and continuing in the in q2 we see some some some improvement and looking at the order book yes the order book is solid we have not seen complete change of pattern so it's solid much better than the beginning of the year but well in line with what we were expecting thank you so regarding your your question on sodash first first disclaimer

uh i would say that uh the who and survey uh process chinese producers according to our estimations were already negative cash negative before the crisis before the conflict so the conflict makes it even worse and probably even more unsustainable okay what we see today two things i would say first we we see a stabilization and potentially a slight recovery even though It's not really obvious, I must say, today, if you look at volumes and prices in China and in Southeast Asia, but certainly at least the stabilization. Then there's a second element that I think is very important, is that we have a big plant in the U.S., SVM, that has shut down. And this will create a lack, a decrease, I would say, of production. So all in all, we expect indeed the situation to, at worst, stabilize, at best, improve.

Martin Rudiger Analyst — Kepler Cheuvreux

Thank you very much.

Operator

The next question is coming from Thomas Rigglesworth from Morgan Stanley. Your line is now open. Please go ahead. Hi there.

Speaker 7

Thanks very much for the opportunity to ask questions and the presentation. Just two questions on the energy exposure slides that you've put up. Firstly, can you help me understand what the implications are behind this for CO2 credits if you're reducing your fossil fuels consumption by 7% divided by 2, let's call it 3% to 4% a year? Is that going to mean that in coming years you'll have more surplus CO2 credits to sell back to the market? And secondly, kind of related, of that energy saving, you know, the total energy spend down 29%, has 100% of that been passed back to customers? That's my energy exposure question. Second question, kind of following up on Martin, around 2Q. So your underlying EBITDA in 1Q, if I strip out the litigation and the CO2 sale, was 174. Can we see a stronger-than-seasonality pickup based on the comments you've just made? Or should we just assume a modest 2Q improvement, more in the lines of kind of 10 to 15 million euros quarter-on-quarter?

Thank you, Tom, for your question. So I will probably let Alex take the last one. For the first one, so CO2 credit surplus. As we explained, I think, already last time, what we're doing is we have a portfolio of different instruments that allow us to balance and manage our CO2 exposure. And this portfolio comprises, you know, three quotas, also CO2 that we have in inventories and purchase in the past, forward purchases, and of course, the energy transition project. So everything that we explain today is part of our analysis and assessment of the portfolio. So I would say this is already somehow included. of course the more we execute the project the more we de-risk our trajectory and so that allows us to indeed optimize the portfolio and valorize some of the co2 instruments that we have in inventory and so on this is what we did this year we will reassess continuously the situation in this portfolio. We don't expect to have a major adjustment to make this year at this point. Do we transfer the savings to the customers? I would say this is a general question that concerns energy savings as well as all the savings that we are generating. Of course, the tighter the markets are, the more we keep, you know, in terms of savings. So very clearly in the current situation, in particular on the soldage market, we are giving a part of these savings to the customers, but that also reinforces our competitiveness. So this is the way it works. Maybe on the last question, Alex, if you can take it.

Sure, thank you. In fact, generally we do not give guidance by quarter, and I think in the current environment, which is, as you know, we have even more reason not to do so. But we are looking at the full year, and given everything we know, we have reconfirmed our full year guidance for EBDA and free cash flow. What you have to keep in mind is there are certain elements which will progressively play more positively in the second part of the year, especially, as we mentioned, COATIS, which was really down for the past few quarters is seeing some improvement and that will continue progressively through the year and obviously the the stranded cost progressively we are reducing uh this uh this cost and the quarter after quarter we'll see some uh some improvement okay thank you very much much appreciated the next question is coming from katie richards from barclays your

Katie Richard Analyst — Barclays

line is not open please go ahead hi good afternoon um yes i had some questions on the energy pass through clauses um which you have spoken about and thank you for the information on the slides it's very useful um i'm just a bit confused because some of your peers have reported that they're seeing little to no price increases in europe for soda rash despite the higher cost energy environments that we're seeing and i guess the speculation that they were making was that this is potentially due to the fact that um some players in europe have decarbonized and now that the plants are running on biomass or waste rather than coal or gas um or maybe as a result of hedging so i guess my question is for the plants which are now 100 biomass based like reinberg can you clarify how the pricing mechanism actually works here and whether it differs from the usual price mechanism that has existed historically and if you could specify as well um what the threshold to pass through this surcharge is in europe please yes no so we have in all of our contracts uh those those energy clauses and this is the case you know since 2021 22 when we had this this big price search search in europe indeed we have thresholds that are let's

say around 50 euro per megawatt hour of natural gas price. That's more or less the way it works. But this is in place, I would say, everywhere in our contract.

Katie Richard Analyst — Barclays

Okay, thank you. And just one other admin question. For Q1, were you affected by the power supply outage and the weather disruption that some of the peers in Wyoming reported in the last quarter.

Where was that? Ah, in Wyoming?

Katie Richard Analyst — Barclays

There was a 20-hour power outage, I believe.

No, not significant. Not significant.

Katie Richard Analyst — Barclays

Sorry, I didn't quite hear.

No, we've not been significantly impacted.

Operator

Okay, thank you. The next question is coming from Anna Harms from BMP Paribas. Your line is now open. Please go ahead.

Anna Harms Analyst — BNP Paribas

Good afternoon. I just wanted to confirm that the improved March wasn't a reflection of any pre-buy and then secondly on the peroxide run rate for the year should we be looking at the revenues you had in Q1 as kind of the the sequential run rate besides obviously the possibility of a license coming in H226 if that's still the case thank you yes so far peroxide no I think you one was as I said earlier on was a little bit softer than expected in particular on the merchant market and we have no license in Q1 and we expect indeed to have this opportunity in the next couple of

quarters or two or three quarters. Did we see any pre-buy? Difficult to say at this point, I don't think we've seen any specifically any pre-buying in March.

No, it was more the So I would say phasing January, February, a little bit soft, things picking up and continuing in future. But we don't see pre-buying.

Anna Harms Analyst — BNP Paribas

Great.

Operator

Thank you. The next question is coming from Julia Winkelmann from Bank of America. Your line is now open. Please go ahead.

Julia Winkelmann Analyst — Bank of America

Hi. Thanks for taking my question. I have a follow-up on paroxides. you said that 2025 was, it seemed like it was exceptionally strong. Could you give more color on the current trends, particularly in the HPPO and intermediaries business, and whether the softness there is cyclical or is it more structural? And then also on HPPO specifically, how should we think about the downside risks to the take or pay contracts? Is there like a floor price that customers pay or how does it work? And then my second question is on the energy transition projects. The 17 million cash out at Donbass in Q1, Can you provide a bit more detail on what's driving these continued cash outflows and whether there is more to come from this particular project? And then for the next project, which was supposed to be the one in Spain, what's the financing structure there and is it already finalized and is there a similar risk on higher costs like similar to what we've seen in Donbassel?

Thank you. okay so uh on on on hppo um i would say what we see today is is uh a relatively stable business except of course for our plant in uh in saudi arabia which is as we said currently uh stopped But what we can say is that this plant in Saudi Arabia, which is one of the three mega plants we have in our industrial chemical platform business, is in a big platform. Right. So we're talking about a platform operated by Sadar, which is a JV between Aramco and Dow Chemicals. It represents $20 billion of assets, and so we are inside this platform operating as a JV with Sadara 50-50, an hydrogen peroxide plant which is currently shut down. We don't expect this plant to restart before Q3, right? And this has been taken into account when we reconfirmed our guidance. So it's within our guidance. On the energy projects, Donbal Energy is a project that we are right now completing. We will still have some cash-outs this year and part of next year. Everything has been provisioned, by the way. And so you will see gradually the cash-outs coming. I remind you that this is a very specific project because we are doing the engineering. And this is why you see the provisions and the cash-out that way. For Spain, it's completely different. We're not doing the engineering, so you won't have this type of impact and mechanisms. You want maybe to complement, Alex?

Yeah, I think in Spain, the technology is also more simple than what is done in France.

Operator

Okay, thank you. The next question is coming from James Hooper from Bernstein. Your line is now open. Please go ahead.

James Hooper Analyst — Bernstein

Hi, thank you. Good afternoon. Thank you for taking the questions. I've got two, please. First is on the digital transformation. I saw recently that you've extended your agreement with IMI. Is this more of a continuation of the existing strategy, or is this an extension? Is this, have you got more to go in terms of savings, digitization beyond the plan? and then secondly is an update on the european carbon proposals we've seen in the press recently there's potential for increases in free allowances perhaps i don't know if you could please give us an update on the one what you've what you're seeing and what your preferred um options would be in terms of european carbon process thank you thank you so no digitalization we continue to run our program.

At this point, and the plan is really to roll out and implement as many, you know, sensors, IOTs as possible in our plans. We are today at 5,000, and I think at the end of this year, we will be at 9,000. So we are roughly halfway. And what we see is that really it delivers, you know, the savings, and even more than I think what we expected, both in terms of fixed costs, so predictive maintenance in particular, and viable costs, so consumptions of energy and raw materials. So we continue with the same dedication and ambition. On the ETS, 2026 is an important year because it's the year where we will start working on the post-2030. And this is very important because it's quite amazing to think that we still don't know what will happen after 2030. And it's very important because what we need is to align the trajectory with the ambition that we have. And the ambition that we have at Solvay, at, you know, a lot of different companies as well, and at the European level, is to become monetary in 2050, not in 2039 or before. And today the ETS is designed such as there is no more free quotas in 2039. So, what we're currently doing is to work with the European Commission to align this trajectory with the real objectives and also with the realistic trajectory that we can achieve. So, basically, keep the ambition but redesign the trajectory so that we avoid having, you know, big disruptions or step changes in terms of free allowances.

Sebastian Bray Analyst — Berenberg

Thank you.

Operator

The next question is coming from Sebastian Bray from Berenberg. Your line is now open. Please go ahead.

Sebastian Bray Analyst — Berenberg

Hello, good afternoon and thank you for taking my question. Can I focus on coartes? Is it going to be, how good is it going to be in Q2, Q3?

Because the commodity chemicals pricing in Brazil is sometimes a little difficult to track but if you look at what the business has done in april and the type of shortage economics that apply could q2 be a record quarter for the business that's my first question i'll pause there well yeah thank you sebastian you want to take it yeah i can take it so again what we are saying it's a commodity which is uh it's a gbu which is more closer to commodity type and which typically behave better when the international index of this kind of product, such as benzene and oil derivative, are higher. It's closer to a spread business. So it's not necessarily the index in Brazil, but the general global index are higher and mechanically it's better. And it's the combination of that plus the fact that some of our Brazilian customers had difficulties to sell to the U.S. because of the 60% tariff that were put in place last year. So there is a demand coming back. And finally, Chinese pressure lowering. The positive impact and the positive momentum will come progressively. It will allow us to get back closer to the mid-cycle. We had some records a few years ago. I don't know yet if we will get back there, but it's more going from below really being at the trough it was a business which is always generating enough cash which is not going into cash burn mode but we were really at the trough we are getting back to uh to mid cycle progressively and we will see h2 being stronger than q2 that's helpful my second one is on special cam There are two parts here.

Sebastian Bray Analyst — Berenberg

The first is for the settlement that was granted as a result of the litigation in AutoCatalyst. I think this litigation had been going on for a decade. Is there any more to come because a 10-year legal case from a 7 million euro payout, it's not huge, but I appreciate these things sometimes happen. And separately, the segment had a bit of a softer quarter, as you said, because of the strong comparables, but electronics markets globally are booming. Why would this segment electronics not do well for the next two or three years exposure-wise?

You want to comment the part on litigation on electronics? Very, very clearly. Yeah, I mean, I agree. We should see, you know, good performance of this market, and this is what we expect. Now, that being said, it's not, of course, a major impact for the group. Let's face it. Alex, you want to comment for the...

Yeah, on the litigation, indeed, this is the last part and we've settled everything that was part of the final settlement with this company on all the IP issues. that's helpful thank you and the last question is coming from chitan udashi your line is now open please go ahead yeah hi thanks for taking my questions the first question was apologies for being direct here but alex i heard you talk about resilient volumes i'm sorry you know your volumes

Chetan Udasi Analyst

are down 15 percent 16 percent versus 2019 levels i mean i don't know how you can call these resilient i mean if i look at your ebitda it's probably down like 30 percent from that same point so i'm just curious you know what makes you think this is a resilient performance uh especially when you strip out the one-off CO2 sale and litigation costs. The second question is just on your rare earth business, you know, there is a huge M&A activity that is happening in the rare earth ecosystem, especially in the U.S. and I'm a bit puzzled how Solvay is not seeing some of that come through. Maybe your positioning in the rarest supply chain is no longer as strategic as it used to be because you probably haven't invested in that business for many years. Why is it that your, not your customers, but all of these ecosystem companies who are building these big mines for the future are not approaching Solvay to essentially sign up? that supply for separation of this business. I would have thought by now, people should be knocking at your doors quite aggressively.

All right, so shall we start with your challenge on our resilience? Thank you very much, by the way, Chetan, for those challenges that are, of course, extremely good questions. And then I will take the one on rare earth, maybe, but I think if you look at the cash that we've generated, you know, over the past years, that makes us think that indeed we have a resilient business.

Yeah, and some of the volume, again, what we've said is we don't want to fight at any price on all volumes, and typically a large part of the decline you've seen is concentrated on seaboard. The fact that we are selling CO2 is also an arbitrage we are doing. Instead of selling at a zero margin or even maybe at a loss, we'd rather monetize the CO2 credit. we have foreseen we had purchased again it's something we have purchased in the past and we driver are monetized and you will see a large part of the of the drop in volume is there it's also a little bit in coates and that's for the reason we have explained if you look at the rest of the business it's been a rather rather rather resilient and of course as you mentioned it's also our ability to adjust capex no i mean yeah i agree and very clearly it's um look at the cash that

we generate in q1 and q1 we know that it's you know uh traditionally a low quarter in terms of cash i'm not sure that you have a lot of companies that are positive in free cash flow uh in q1 you And this also shows that we have not taken any specific measure end of last year to make it better in 2025. So we're really resilient in that way. We are delivering cash quarter after quarter in a very consistent way, whatever the market is. Now, on rare earth, thank you very much for the challenge. Don't worry. We're working on it. We, by the way, have started production of NDPR last year. We have started production of samarium, yttrium, and gadolinium. We will start in the coming weeks production of DYTB. It will be the first time ever in Europe that someone is producing DYTB. So we are not inactive. We are doing, you know, things that have never been done outside of China in the past. And it's not because we're not communicating permanently on this, maybe as opposed to others.

Chetan Udasi Analyst

Then we are not acting. we are constantly reviewing uh our portfolio and ensure alignment with our long-term strategy and capital allocation priorities all the time thank you can i follow can i follow up on uh yes on just second quarter uh i know you don't want to give guidance specifically but i was just trying to do some math i mean if i take your q1 if i strip out all of the one-offs you are probably at like 180 million uh run rate in q1 if i just assume 180 per quarter for the remainder of the year you just get up you know to something like 760 which is pretty much the low end

of your of your guidance i'm just curious to get to the midpoint what are you assuming i mean should the next couple of quarters be better than 180 because of seasonality and some other factors or how are you thinking about that phasing you know by quarter basically yeah no i mean well as alex said i mean of course q2 is difficult to say we know that the net uh impact of the middle east crisis conflict is probably slightly negative even with the the positive impact on qatis but but it's very difficult to to give exactly a number What we know, however, is that H2 should be better than H1 for different reasons. First, our stranded costs will decrease quarter after quarter, so they will be lower in H2 versus H1. And then we are also working on a certain number of business opportunities, as usual, and in particular, peroxide license, which should land probably somewhere in H2. So that's why we reconfirmed the guidance exactly as it was issued at the beginning of the year.

Chetan Udasi Analyst

That's clear.

Thank you. You're welcome, Chetan.

Operator

We have a follow-up question from Katie Richards from Barclays. Your line is now open. Please go ahead.

Katie Richard Analyst — Barclays

Just a few follow-ups. Firstly, on the rare-rest comment you just made there, do you think that the reason you're not getting some funding is actually due to your positioning in the value chain? in the sense that Solvay is more in the purification end, if I understand correctly, rather than the mining, the extraction itself. And I just wanted to check that, assuming about a 10 million EBITDA annualized for the peroxides, JV would be sensible for the year.

Okay, so I will let Alex maybe comment on the peroxide plan, but no, for Rare Earth, I mean, very clearly, we are supported. I mean, very clearly today, we have the support of the French government to invest in our capacity expansion in France. So and by the way, the separation step is probably the one that is the most difficult to achieve and where you have really a strong differentiation in terms of process and technological know-how. So, no, what matters, what is today the limiting factor, I would say, is the development of the whole value chain, right? it's not our step in particular is that from mining to the electric motor you need to have a consistent valorization I would say to make all those projects happen and this is what we're doing when we talk to both the European and the American policymakers is we're trying and the Japanese by the way as well. They are all working in order to create the right profitability for the whole value chain in order to have those investments. Now on peroxide...

Just to add also on the errors, I mean it's not the funding which is a problem. I mean this funding, it's really the operating model. We don't want to invest ahead of demand without having certain form of certainty on the output. And as I said, today, I mean, we have a few customers, small ones, this is why it's not moving the level in our Q1 reserve, but there is a little bit of contribution also because we want to demonstrate our capability to produce these categories of errors that we are the only one, but we will not invest before we have a certain form of certainty. Getting back to peroxide GV, again, sorry, but we cannot comment. You first have to understand the situation is extremely complex to manage. Philippe described how big, and this is the biggest chemical complex in the world, and we are just a small piece of that.

Geoffroy Loutremont Head of Investor Relations

So what the only thing we can say is that in our guidance we reconfirm the full guidance assuming the overall platform will remain closed will remain shut down in in k2 thank you thank you there are no more questions at this time so i hand the conference back to the speakers for any closing remarks thank you gaya and thank you all for your participation today if you have any questions please feel free to reach out to the IR team and there are a few role shows and conferences that are planned later in may and june as always you can find them on the financial calendar page on our website and our q2 earnings will be published on july the 29th thank Thank you very much.

Analyst Q&A · 8 questions
Full-screen source Call document